Chapter 982 Change of coach?

The biggest event in European political life this year may be the European Parliament election to be held in May this year, which is a five-year election.

At that time, voters across the EU will vote to directly elect 751 members of the European Parliament.

Related to this is the change of leadership of the President of the European Council, the President of the European Commission, the High Representative of the European External Action Service, and the change of the Secretary-General of NATO.

At present, Europe is in the context of the gradual easing of the sovereign debt crisis. In the process of the EU integration process being "forced" by the crisis, this European Parliament election will have a certain impact on the future political and economic situation in Europe, the development of the EU, and even global international relations.

However, in contrast, before this, European voters were not very enthusiastic about the general election of the European Parliament.

According to relevant data, due to the general indifference of voters to European politics, coupled with distrust of EU institutions and leaders and dissatisfaction with their "untrustworthiness", "inefficiency", "lack of fairness" and "lack of transparency", the direct election of the European Parliament has been declining in EU member states.

In 1979, the voter turnout rate was 62% when there were 9 EU member states, and it dropped to 56.8% when there were 12 member states in 1994, 49.5% when there were 15 member states in 1999, and 45.5% when there were 25 member states in 2004. Until the last European Parliament election in 2009, the average voter turnout rate of 27 member states was only 43%.

According to relevant forecasts, the possibility of the voter turnout rate exceeding 50% in this year's European Parliament election is still small.

However, what is worrying is that ordinary voters are not interested in voting, but the supporters of the extreme right forces are eager to use this opportunity to vent their dissatisfaction with EU integration.

Beatrice Borromeo naturally knows Barron's attitude. He supports European integration. After all, he has invested a lot of industries in various European countries, and European integration is conducive to his use of the unified market of the whole Europe.

But the actual situation is that there are still many obstacles to European integration.

The simplest point is that it is difficult to unify the language, which is also the difficulty of promoting many industries in Europe, including the Internet.

Speaking of this, the value of the "same writing system and same track system" of Qin Shihuang of China is fully demonstrated.

You can imagine that the EU currently has 27 member states with a total area of ​​about 4.322 million square kilometers, and almost every member state of the EU has its own unique language.

That is to say, in this area less than half of China, there are 24 official languages ​​- this situation is almost equivalent to China not having standard Mandarin, but each province using "dialects" with different pronunciations and writing. Just imagine how chaotic this situation is.

You said the EU has a unified language? Then which language should be used? Although English is the most widely used language in the world and can be called "Esperanto", do I agree with France? French has always been the "noble language" of Europe...

And Spanish, your English and French are widely used in the world, so is my Spanish any worse? Spanish is also widely used in Latin America.

This is not over yet. As the current locomotive of the EU economy, does German not deserve a place?

Moreover, with the "democracy" system in Europe, how can such language unification be forced? They don't have a strong central government, and trivial matters can be discussed for years...

...

After Beatrice Borromeo left England, Barron was finally ready to meet with the board of directors of GlaxoSmithKline.

Last year, DS Group, operated by Daisy, shorted GlaxoSmithKline, the largest pharmaceutical company in England. With the profits from this shorting, DS Group then bought some shares of GlaxoSmithKline...

Currently, they hold nearly 10% of GlaxoSmithKline's shares and are one of the company's major shareholders.

When DS Group shorted GlaxoSmithKline, the company was caught up in an investigation of commercial bribery by China and the United States. It can be said that GlaxoSmithKline's management has "greeted" the other party in private.

But now the situation is stronger than people. DS Group has become a major shareholder of GlaxoSmithKline, and their funds, including the European Wealth Fund, which was just established, are continuing to acquire the holdings of some institutions. I believe they will soon become the largest shareholder of GlaxoSmithKline. In this case, coupled with Barron's power in the West, it is not wise to continue to oppose this capital tycoon.

"I support GlaxoSmithKline to make some changes, gentlemen."

Barron met with GlaxoSmithKline's board members at Chatsworth Manor, well, it looks more like a "reception".

He said to these people:

"I understand that the R\u0026D investment in oncology drugs is huge and has considerable risks, but I still think that even if the oncology drugs and consumer health products businesses are split, the best way is to form a joint venture with other companies' related businesses, and we retain shares..."

In fact, Andrew Witty, the current CEO of GlaxoSmithKline, looks at the oncology drug business in this way, believing that it requires huge investment and has a high failure rate - he is considering selling or exchanging GlaxoSmithKline's oncology drug business for vaccines or OTC (over-the-counter drugs) businesses that he is interested in.

But Barron knows that GlaxoSmithKline, led by Andrew Witty, did not have ideal revenue in the future, which also caused its stock price performance to be inferior to other pharmaceutical giants.

Reading the error-free version! 6=9+Shu_bar first releases this novel.

Barron does not want to wait until a new CEO is needed to adjust the development route of GlaxoSmithKline adjusted by Andrew Witty back...

Therefore, when he decided to become a major shareholder of GlaxoSmithKline, Andrew Witty's fate was already determined.

He can no longer wait until GlaxoSmithKline falls out of the top ten global pharmaceutical companies in 2017 as in the original time and space, and then dismiss Andrew Witty.

Although DS Group currently only holds about 10% of GlaxoSmithKline shares, the funds under his control are still buying GlaxoSmithKline shares from other institutions. Compared with last year, GlaxoSmithKline's stock price has risen a lot, which has also given some institutions the idea of ​​"jumping ship" and selling GlaxoSmithKline shares.

When he becomes the major shareholder of GlaxoSmithKline, he will start contacting other shareholders to replace the CEO.

It seems that Emma Walmsley, who later took over the position of CEO of GlaxoSmithKline in the original time and space, performed well. Now she is working for the L'Oreal Group under the GHL Group.